A detailed history of Franklin Resources Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 20,253 shares of AUPH stock, worth $171,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,253
Previous 95,277 78.74%
Holding current value
$171,947
Previous $544,000 72.79%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.32 - $7.33 $399,127 - $549,925
-75,024 Reduced 78.74%
20,253 $148,000
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $58,956 - $70,845
12,257 Added 14.76%
95,277 $544,000
Q1 2024

May 13, 2024

SELL
$4.93 - $9.31 $478 - $903
-97 Reduced 0.12%
83,020 $415,000
Q4 2023

Feb 09, 2024

SELL
$7.13 - $9.49 $28,741 - $38,254
-4,031 Reduced 4.63%
83,117 $747,000
Q3 2023

Nov 13, 2023

SELL
$7.77 - $12.27 $8,671 - $13,693
-1,116 Reduced 1.26%
87,148 $677,000
Q2 2023

Aug 11, 2023

BUY
$8.96 - $11.69 $790,845 - $1.03 Million
88,264 New
88,264 $854,000
Q1 2021

May 13, 2021

SELL
$12.3 - $18.73 $477,240 - $726,724
-38,800 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$12.94 - $16.05 $172,102 - $213,465
13,300 Added 52.16%
38,800 $535,000
Q3 2020

Nov 12, 2020

SELL
$13.19 - $16.66 $14.9 Million - $18.9 Million
-1,133,100 Reduced 97.8%
25,500 $375,000
Q2 2020

Aug 13, 2020

SELL
$14.12 - $18.33 $1.43 Million - $1.85 Million
-101,000 Reduced 8.02%
1,158,600 $19.3 Million
Q1 2020

May 13, 2020

SELL
$11.34 - $21.46 $775,656 - $1.47 Million
-68,400 Reduced 5.15%
1,259,600 $18.3 Million
Q4 2019

Feb 12, 2020

SELL
$3.88 - $21.42 $308,460 - $1.7 Million
-79,500 Reduced 5.65%
1,328,000 $26.9 Million
Q2 2019

Aug 14, 2019

SELL
$6.05 - $6.75 $1.24 Million - $1.39 Million
-205,400 Reduced 12.73%
1,407,500 $9.26 Million
Q1 2019

May 14, 2019

SELL
$6.06 - $7.64 $1.37 Million - $1.72 Million
-225,600 Reduced 12.27%
1,612,900 $10.5 Million
Q3 2018

Nov 13, 2018

BUY
$5.27 - $6.64 $554,931 - $699,192
105,300 Added 6.08%
1,838,500 $12.2 Million
Q2 2018

Aug 14, 2018

BUY
$5.06 - $6.36 $348,128 - $437,568
68,800 Added 4.13%
1,733,200 $9.76 Million
Q4 2017

Feb 14, 2018

BUY
$4.53 - $7.09 $1.88 Million - $2.94 Million
414,400 Added 33.15%
1,664,400 $7.54 Million
Q3 2017

Nov 13, 2017

BUY
$5.71 - $6.9 $7.14 Million - $8.63 Million
1,250,000
1,250,000 $7.84 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.2B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.